iSpecimen (ISPC) Preferred Stock Liabilities (2020 - 2021)
iSpecimen (ISPC) recorded quarterly Preferred Stock Liabilities of $561041.0 in Q1 2021, down 94.98% quarter-over-quarter from $11.2 million in Q4 2020.
iSpecimen (ISPC) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends
iSpecimen's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $561041.0 for Q1 2021.
- In Q1 2021, Preferred Stock Liabilities changed N/A year-over-year to $561041.0; the TTM figure through Mar 2021 stood at $561041.0 (changed N/A YoY), while the FY2020 annual figure was $11.2 million, changed N/A from the prior year.
- Preferred Stock Liabilities was $561041.0 for Q1 2021 at iSpecimen, down from $11.2 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $11.2 million in Q4 2020 to a low of $561041.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | - |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | - |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | - |
| 10 | iSpecimen | 1.02 Mn | -1.79 Mn | -1.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 561,041.00 |
| Dec 31, 2020 | 11.17 Mn |
| Sep 30, 2020 | 8.00 Mn |
| Jun 30, 2020 | 2.61 Mn |